An increase was detected in the ratios of CD8+IFNγ+/CD4+FoxP3+ T cells and CD8+IFNγ+/CD11b+Ly6G+ cells in pHIFU + ICI-treated tumours relative to controls. The gene discussed is CD8A; the disease is neoplasm.